The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
eFFECTOR Therapeutics, Inc. Common Stock 28202V108   851,534 1,025,697 SH   SOLE   1,025,697 0 0
PMV Pharmaceuticals, Inc. Common Stock 69353Y103   6,192,592 989,232 SH   SOLE   989,232 0 0
Cyteir Therapeutics, Inc. Common Stock 23284P103   6,394,887 2,459,572 SH   SOLE   2,459,572 0 0
Homology Medicines, Inc. Common Stock 438083107   56,640 64,000 SH   SOLE   64,000 0 0
Precision BioSciences, Inc. Common Stock 74019P108   591,178 1,123,913 SH   SOLE   1,123,913 0 0
Selecta Biosciences, Inc. Common Stock 816212104   966,048 862,543 SH   SOLE   862,543 0 0
Spero Therapeutics, Inc. Common Stock 84833T103   361,152 249,070 SH   SOLE   249,070 0 0
Centessa Pharmaceuticals plc Sponsored ADS 152309100   18,183,837 2,937,615 SH   SOLE   2,937,615 0 0
Aerovate Therapeutics Inc. Common Stock 008064107   10,354,518 603,762 SH   SOLE   603,762 0 0
DICE Therapeutics Inc. Common Stock 23345J104   12,467,355 268,346 SH   SOLE   268,346 0 0
Graphite Bio Common Stock 38870X104   1,056,401 406,308 SH   SOLE   406,308 0 0
Vor Biopharma Inc. Common Stock 929033108   1,157,866 374,714 SH   SOLE   374,714 0 0